JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:288; doi:10.1136/jnnp.2005.075879
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dippel, D W J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dippel, D W J
Topic Collections
Right arrowRelevant Article

EDITORIAL COMMENTARY

Stroke outcome

National variations in mortality and functional outcome: should we be worried?

D W J Dippel

Correspondence to:
Correspondence to:
Dr Diederik W J Dippel
Department of Neurology, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands; d.dippel@erasmusmc.nl


International registries should be established to monitor process and outcome of care after stroke

Keywords: national; outcome; quality; stroke; survey

The first 150 words of the full text of this article appear below.

The ultimate goal of our efforts in (pre-)clinical stroke research and patient management is to deliver effective and high quality care at reasonable cost. It follows that we should be able to measure the results of the delivery of stroke care on an aggregate level, and, when variations at the hospital or national level are encountered, we should be able to point out the factors that cause this variation. This is not easily done.

In this issue, Gray et al (see pages 327–33) present an analysis of national variations in mortality and functional outcome after stroke.1 This substudy was based on the data from a large randomised multicentre trial of a low molecular weight heparin, tinzaparin.2 Outcome was defined as death or dependency at 6 months from onset of stroke. The authors point out that one would expect outcomes to be similar throughout the western . . . [Full text of this article]


Relevant Article

Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)
L J Gray, N Sprigg, P M W Bath, P Sørensen, E Lindenstrøm, G Boysen, P P De Deyn, P Friis, D Leys, R Marttila, J-E Olsson, D O’Neill, B Ringelstein, J-J van der Sande, A G G Turpie for the TAIST Investigators
J. Neurol. Neurosurg. Psychiatry 2006 77: 327-333. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.